|
(b)(4).This is a combination product, and the event has been reviewed for both the suture and the triclosan.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.A manufacturing record evaluation was performed for the finished device qmmaeb batch number, and no non-conformances were identified.(b)(4).To date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent.Trade name - irgacare®, active ingredient(s) ¿ triclosan, dosage form ¿ suture/solid/parenteral, strength ¿ = 275 g/m.
|
|
It was reported that a patient underwent a c-section on (b)(6) 2022 and suture was used.During the procedure, the problem of pulling off suture needle happened.A new suture was replaced immediately.The doctor was a senior doctor, and the operation was carried out smoothly.There were no adverse patient consequences reported.No additional information could be provided.
|